The Jerusalem PostLod mayor ‘seething’ after Jewish-Arab clashes, right-wing activist summoned for questioningInquirerIlocos Sur town sets P180 minimum farmgate price for live hogsPunchDon’t politicise sports, Presidency tells Obi over Flamingos greetingDaily MaverickRENEWABLES CRISIS : Pele’s governance test: Why a private boardroom matters to SA’s energy transitionZDF heuteEntdecken Sie das ZDF-NachrichtenstudioSRF NewsSchauspieler und Comedian – Über zehn Jahre Haft für Russell BrandIl Fatto QuotidianoLe renne che nuotano per la migrazione invernale: le incredibili immagini che arrivano dalla Norvegia – VIDEOCollider‘The Acolyte’ Director’s New Thriller Officially Scores ‘The Wheel of Time’ StarScreen RantPlayStation Officially Announces All-New ConsoleDigital Spy"What is going on?": Former Strictly star Oti Mabuse hits out at the judges' scoringCBS NewsHow to qualify for credit card debt forgiveness in 2027ABC NewsRussell Brand sentenced to 10 years 6 months in prison for rape, sexual assault
KioskNews
The Daily Newsstand · Free, Always
Monday, November 9, 2026
Language
Seeking Alpha·United States·

Mereo BioPharma Group GAAP EPS of -$0.01 in-line, revenue of $0.80M

Translate

Urvi Shah

  • Mereo BioPharma Group press release (MREO): Q3 GAAP EPS of -$0.01 in-line.
  • Revenue of $0.80M.
  • As of September 30, 2026, the Company had cash and cash equivalents of $26.1 million, compared to $41.0 million as of December 31, 2025.

Recommended For You

Register for free to keep reading.

Create a free account to get unlimited breaking news and alerts when your stocks move.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.